Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for mmv medicines for malaria venture in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (16)
Results: 1-16 | Export
  1. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 6 of 6 (2020-08-31 to 2021-06-24)
    Posted: 2020-09-01
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  2. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: CHARLES BIRD, Earnscliffe Ontario Inc
    Registration: 1 of 1 (2020-03-23 to 2021-03-31)
    Posted: 2020-05-06
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  3. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 5 of 6 (2019-10-31 to 2020-08-31)
    Posted: 2019-10-31
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  4. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Registration: 9 of 9 (2019-10-31 to 2019-12-05)
    Posted: 2019-10-31
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: Yes
  5. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 4 of 6 (2017-09-29 to 2019-10-31)
    Posted: 2017-10-03
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  6. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Registration: 8 of 9 (2017-06-15 to 2019-10-31)
    Posted: 2017-06-28
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: Yes
  7. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 3 of 6 (2017-03-31 to 2017-09-29)
    Posted: 2017-04-13
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  8. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 2 of 6 (2016-06-30 to 2017-03-31)
    Posted: 2016-06-30
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  9. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Registration: 7 of 9 (2016-06-14 to 2017-06-15)
    Posted: 2016-06-30
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  10. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Registration: 1 of 6 (2015-10-20 to 2016-06-30)
    Posted: 2015-10-21
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  11. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Registration: 6 of 9 (2015-10-14 to 2016-06-14)
    Posted: 2015-10-16
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
  12. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Registration: 5 of 9 (2015-04-15 to 2015-10-14)
    Posted: 2015-04-17
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: Yes
  13. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Registration: 4 of 9 (2014-12-15 to 2015-04-15)
    Posted: 2014-12-15
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: Yes
  14. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Registration: 3 of 9 (2014-10-14 to 2014-12-15)
    Posted: 2014-10-15
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: Yes
  15. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Registration: 2 of 9 (2014-09-25 to 2014-10-14)
    Posted: 2014-09-25
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: Yes
  16. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Registration: 1 of 9 (2014-09-19 to 2014-09-25)
    Posted: 2014-09-19
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
Monthly communication reports (65)
Results: 1-50 | Export
  1. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-11-23
    Posted: 2018-12-15
    Designated public office holders:
    • Peter Boehm, Senator | Senate of Canada
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  2. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2018-11-23
    Posted: 2018-12-15
    Designated public office holders:
    • Monique Lugli, Chief of Staff, Office of the Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  3. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-11-22
    Posted: 2018-12-15
    Designated public office holders:
    • Kathleen Davis, Special Assistant, Global Support | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • International Development
    • Research and Development
      •
  4. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2018-11-22
    Posted: 2018-12-15
    Designated public office holders:
    • Kathleen Davis, Special Assistant, Global Support | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  5. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-11-22
    Posted: 2018-12-15
    Designated public office holders:
    • Emily Yorke, Policy Advisor, Office of the Minister | Finance Canada (FIN)
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  6. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-11-22
    Posted: 2018-12-15
    Designated public office holders:
    • Hilary Travis, Policy Advisor, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Development
    • Research and Development
    • Health
      •
  7. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2018-11-22
    Posted: 2018-12-15
    Designated public office holders:
    • David Morrison, Associate Deputy Minister of Foreign Affairs | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
    • Health
    • Research and Development
      •
  8. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-05-03
    Posted: 2018-06-15
    Designated public office holders:
    • Hilary Travis, Special Assistant, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
      •
  9. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2018-05-02
    Posted: 2018-06-15
    Designated public office holders:
    • Monique Lugli, Senior Advisor, Office of the Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  10. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-04-18
    Posted: 2018-05-15
    Designated public office holders:
    • Emily Yorke, Policy Advisor, Office of the Minister | Finance Canada (FIN)
    Subject matters:
    • International Development
      •
  11. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2018-04-18
    Posted: 2018-05-15
    Designated public office holders:
    • Kathleen Davis, Special Assistant | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  12. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2018-04-18
    Posted: 2018-05-18
    Designated public office holders:
    • Raj Saini, Member of Parliament | House of Commons
    Subject matters:
    • International Development
    • Health
    • Research and Development
      •
  13. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-10-31
    Posted: 2017-11-15
    Designated public office holders:
    • Lara Pocock, Policy Advisor, Office of the Minister of International Development | Global Affairs Canada (GAC)
    • Claude Thibault, Senior Policy Advisor, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  14. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Mobina Jaffer, Senator | Senate of Canada
    Subject matters:
    • Research and Development
    • International Development
    • Health
      •
  15. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Lara Pocock, Policy Advisor, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • International Development
    • Research and Development
      •
  16. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Pierre-Yves Bourque, Legislative Assistant, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
    • Research and Development
    • Health
      •
  17. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Hana Button, Director of Policy, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  18. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Javid Dharas, Policy Advisor, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • International Development
    • Health
      •
  19. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Celina Caesar-Chavannes, Parliamentary Secretary to the Minister of International Development | House of Commons
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  20. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Stephanie Delorme, Stakeholder Relations Advisor, Office of the Leader of the Official Opposition | House of Commons
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  21. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Andrea Faubert, Policy Advisor, Office of the Leader of the Official Opposition | House of Commons
    Subject matters:
    • Research and Development
    • International Development
    • Health
      •
  22. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Alexander Slusar, Policy Analyst, Office of the Minister | Veterans Affairs Canada (VAC)
    Subject matters:
    • Research and Development
    • International Development
    • Health
      •
  23. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Kent Hehr, Minister | Veterans Affairs Canada (VAC)
    Subject matters:
    • Health
    • International Development
    • Research and Development
      •
  24. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-17
    Posted: 2017-06-15
    Designated public office holders:
    • Paul McCarthy, Director of Policy, Office of the Minister | Veterans Affairs Canada (VAC)
    Subject matters:
    • International Development
    • Research and Development
    • Health
      •
  25. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2017-05-16
    Posted: 2017-06-15
    Designated public office holders:
    • Kelvin Kenneth Ogilvie, Senator | Senate of Canada
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  26. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-29
    Posted: 2016-12-15
    Designated public office holders:
    • Christina Rettig, Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • International Development
      •
  27. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-29
    Posted: 2016-12-15
    Designated public office holders:
    • Christina Rettig, Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • International Development
      •
  28. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-04
    Posted: 2016-12-15
    Designated public office holders:
    • Russell Milon, Director of Parliamentary Affairs, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • International Development
      •
  29. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-04
    Posted: 2016-12-15
    Designated public office holders:
    • Peter Boehm, Deputy Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • International Development
      •
  30. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-04
    Posted: 2016-12-15
    Designated public office holders:
    • Tyler Meredith, Policy Advisor | Prime Minister's Office (PMO)
    • Emmaline English, Special Assistant | Prime Minister's Office (PMO)
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • International Development
    • Health
      •
  31. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-11-04
    Posted: 2016-12-15
    Designated public office holders:
    • Ian Foucher, Policy Advisor, Office of the Minister | Finance Canada (FIN)
    Subject matters:
    • Health
    • International Development
      •
  32. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-09-16
    Posted: 2016-10-15
    Designated public office holders:
    • Karina Gould, Parliamentary Secretary, Minister of International Development and Minister for La Francophonie | House of Commons
    Subject matters:
    • International Development
      •
  33. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-09-16
    Posted: 2016-10-15
    Designated public office holders:
    • Karina Gould, Parliamentary Secretary, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  34. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-08-15
    Posted: 2016-09-15
    Designated public office holders:
    • Hanna Button, Policy Advisor, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
    • Health
      •
  35. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-06-14
    Posted: 2016-07-15
    Designated public office holders:
    • Marc Miller, Member of Parliament | House of Commons
    Subject matters:
    • International Development
      •
  36. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-06-08
    Posted: 2016-07-15
    Designated public office holders:
    • Russell Milon, Director of Parliamentary Affairs, Office of the Minister of International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  37. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-05-19
    Posted: 2016-06-15
    Designated public office holders:
    • Peter Boehm, Deputy Minister, International Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  38. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  39. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Kelvin Kenneth Ogilvie, Senator | Senate of Canada
    Subject matters:
    • Health
    • International Development
    • Research and Development
      •
  40. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Russell Milon, Director of Parliamentary Affairs, Office of the Minister | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  41. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Russell Milon, Director of Parliamentary Affairs, Office of the Minister | Global Affairs Canada (GAC)
    Subject matters:
    • International Development
      •
  42. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Research and Development
    • Health
    • International Development
      •
  43. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Kelvin Kenneth Ogilvie, Senator | Senate of Canada
    Subject matters:
    • Health
    • Research and Development
    • International Development
      •
  44. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: DANIEL BERNIER, Earnscliffe Strategy Group
    Occurred: 2016-03-08
    Posted: 2016-07-20
    Designated public office holders:
    • Karina Gould, MP, Parliamentary Secretary to the Minister of International Development | House of Commons
    Subject matters:
    • International Development
      •
  45. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2016-03-08
    Posted: 2016-07-20
    Designated public office holders:
    • Karina Gould, MP, Parliamentary Secretary to the Minister of International Development | House of Commons
    Subject matters:
    • International Development
      •
  46. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, Earnscliffe Strategy Group Inc.
    Occurred: 2015-11-03
    Posted: 2015-12-15
    Designated public office holders:
    • Mobina Jaffer, Senator | Senate of Canada
    Subject matters:
    • International Development
      •
  47. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Occurred: 2015-05-28
    Posted: 2015-06-15
    Designated public office holders:
    • Paul Calandra, Parliamentary Secretary | House of Commons
    Subject matters:
    • International Development
      •
  48. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Occurred: 2015-05-27
    Posted: 2015-06-15
    Designated public office holders:
    • Kelvin Ogilvie, Senator | Senate of Canada
    Subject matters:
    • International Development
      •
  49. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Occurred: 2015-05-27
    Posted: 2015-06-15
    Designated public office holders:
    • Michelle Rempel, Minister of State (Western Economic Diversification) | Western Economic Diversification Canada (WD)
    Subject matters:
    • International Development
      •
  50. MMV Medicines for Malaria Venture
    Type: Consultant
    Lobbyist: Paul Moen, MoenGlobal Advisors Inc.
    Occurred: 2015-05-27
    Posted: 2015-06-15
    Designated public office holders:
    • Lynn Yelich, Minister of State (Foreign Affairs & Consular) | Foreign Affairs, Trade and Development Canada
    Subject matters:
    • International Development
      •
Date Modified: